Stocks / NASDAQ / Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Our Opinion

Alnylam Pharmaceuticals, Inc. is on the Cruelty Free Investing use of animals list because they test their drugs on pre-clinical animal models – mouse, rat and non-human primate.

Additional resources:

The following release cites use of “three pre-clinical animal models – mouse, rat and non-human primate”

Alnylam Presents Pre-clinical Data from Hypercholesterolemia, Liver Cancer, Ebola, and Progressive Multifocal Leukoencephalopathy (PML) Programs at RNAi Keystone Symposium.

Company Description

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Website: http://www.alnylam.com